Boiron: sales down by almost 7% in 1st half-year
Excluding Covid tests, the laboratory's sales were up 6.2%, with growth across all geographic regions, driven by sales of homeopathic specialties (+12.3%).
"The evolution of the Group's sales over 2023 will depend on the continuation of the current momentum in homeopathic specialties, future launches and the level of pathology at the end of the year", says Boiron.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction